Pathologic Processes Clinical Trials
2 recruiting trials for Pathologic Processes. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Pathologic Processes clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Every phased trial in this set is Phase 2 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.
Research is led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1), Ottawa Hospital Research Institute (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Allogeneic umbilical cord-derived human mesenchymal stromal cells (biological, 1 trial), followed by Placebo.
Track Pathologic Processes trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Testing VIRTUES Patient Care Sets in Cardiac Patients (VIRTUES Cardiac Care)
Patients with various cardiac conditions (such as those who experience a heart attack) are increasing in Canada and are in need of appropriate cardiac rehabilitation and care....
Umbilical Mesenchymal Stromal Cells as Cellular Immunotherapy for Septic Shock
Septic shock is associated with substantial burden in terms of both mortality and morbidity for survivors of this illness. Pre-clinical sepsis studies suggest that mesenchymal...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Pathologic Processes, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Pathologic Processes, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Pathologic Processes, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.